2018
Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study
Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study. AIDS And Behavior 2018, 22: 2640-2649. PMID: 29582199, PMCID: PMC6051885, DOI: 10.1007/s10461-018-2099-0.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidBiobehavioral SciencesCondomsFeasibility StudiesFemaleHIV InfectionsHumansMaleMedication AdherenceMethadoneMiddle AgedMotivationOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePilot ProjectsPre-Exposure ProphylaxisProspective StudiesRisk Reduction BehaviorSexual BehaviorSexual PartnersSubstance Abuse, IntravenousConceptsPre-exposure prophylaxis adherenceSelf-reported PrEP adherenceSex-related risk behaviorsHIV risk reduction behaviorsBio-behavioral interventionPre-exposure prophylaxisProspective clinical trialsHigh-risk peopleHIV prevention interventionsHIV risk behaviorsPilot feasibility studyPost-intervention assessmentPrEP adherenceProphylaxis adherencePreliminary efficacyClinical trialsIntervention groupHIV riskPrevention interventionsRisk behaviorsBio-behavioral approachAdherenceInterventionHigh acceptabilityPrEP
2017
Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research
Shrestha R, Altice F, Karki P, Copenhaver M. Developing an Integrated, Brief Biobehavioral HIV Prevention Intervention for High-Risk Drug Users in Treatment: The Process and Outcome of Formative Research. Frontiers In Immunology 2017, 8: 561. PMID: 28553295, PMCID: PMC5425476, DOI: 10.3389/fimmu.2017.00561.Peer-Reviewed Original ResearchNeurocognitive impairmentHigh-risk drug usersBehavioral interventionsHigh-risk PWUDHIV prevention behavioral interventionBiobehavioral approachHIV risk reductionHIV prevention interventionsDrug treatment settingsFormative researchHIV prevention effortsTarget populationPrEP adherencePrEP uptakeRisk reduction outcomesHIV preventionDrug treatmentPrevention interventionsFocus groupsTreatment settingsDrug usersRecovery programStructured focus groupsRisk behaviorsTarget population members
2015
HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling
Bazazi AR, Crawford F, Zelenev A, Heimer R, Kamarulzaman A, Altice FL. HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling. AIDS And Behavior 2015, 19: 2347-2357. PMID: 26358544, PMCID: PMC4743744, DOI: 10.1007/s10461-015-1191-y.Peer-Reviewed Original ResearchConceptsHIV prevalenceHIV epidemicPrevention interventionsRapid HIV testingHIV prevention interventionsRespondent-driven samplingHIV testingAppropriate treatmentHigh prevalencePWIDCommunity surveillanceKuala LumpurPrevalenceBehavioral assessmentOverall sampleDrugsInterventionRecruitment sitesEpidemicInterview siteHIVGeographic regionsGreater Kuala LumpurDiscrete geographic regionsLumpurCost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States
Song DL, Altice FL, Copenhaver MM, Long EF. Cost-Effectiveness Analysis of Brief and Expanded Evidence-Based Risk Reduction Interventions for HIV-Infected People Who Inject Drugs in the United States. PLOS ONE 2015, 10: e0116694. PMID: 25658949, PMCID: PMC4320073, DOI: 10.1371/journal.pone.0116694.Peer-Reviewed Original ResearchConceptsQuality-adjusted life yearsOpioid substitution therapyHIV infectionHIV incidenceHIV prevalenceEvidence-based risk reduction interventionDynamic HIV transmission modelHolistic Health Recovery ProgramBehavioral HIV prevention interventionsFuture HIV incidenceTotal medical costsHIV transmission modelHIV prevention interventionsGeneral adult populationRisk reduction interventionsCost-effectiveness analysisSubstitution therapySexual transmissionHIV programsPrevention interventionsMedical costsTreatment settingsLife yearsReduction interventionsUS population
2013
A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment
Vagenas P, Azbel L, Polonsky M, Kerimi N, Mamyrov M, Dvoryak S, Altice FL. A review of medical and substance use co-morbidities in Central Asian prisons: Implications for HIV prevention and treatment. Drug And Alcohol Dependence 2013, 132: s25-s31. PMID: 23932844, PMCID: PMC3825758, DOI: 10.1016/j.drugalcdep.2013.07.010.Peer-Reviewed Original ResearchConceptsOpioid substitution therapyDrug-related health problemsHIV preventionHealth problemsHIV sentinel surveillanceHIV prevention interventionsConcentration of HIVHIV incidenceHIV casesSubstitution therapyHIV prevalenceSentinel surveillancePrevention interventionsRisk populationsDisease RegistryTreatment servicesHealth reportingSubstance useHealthcare servicesRecent dataPrevalenceCrucial interventionPreventionInterventionOnline databases
2007
The Association Between History of Violence and HIV Risk A Cross-Sectional Study of HIV-Negative Incarcerated Women in Connecticut
Ravi A, Blankenship KM, Altice FL. The Association Between History of Violence and HIV Risk A Cross-Sectional Study of HIV-Negative Incarcerated Women in Connecticut. Women's Health Issues 2007, 17: 210-216. PMID: 17570681, DOI: 10.1016/j.whi.2007.02.009.Peer-Reviewed Original ResearchConceptsUnprotected sexUnprotected sex practicesNonprimary partnersHistory of violencePrimary partnersSex practicesMale primary partnerIncarcerated womenMultivariate logistic regressionHIV prevention interventionsHIV prevention agendaHIV infectionSectional studyHIV riskPrevention interventionsFuture longitudinal researchHealth historyDrug useSexual partnersLogistic regressionRisk APrevention agendaPhysical violenceWomenWomen's background